LOAD MORE
You're viewed all 13 products
Sorafenib
References
FAQ's
References
Frequently Asked Questions
What steps can control impurity levels in Sorafenib during manufacturing?
Manufacturers can adopt several strategies to maintain control over impurity levels in Sorafenib. They include using high-quality starting materials, optimizing synthesis and purification processes, implementing comprehensive quality control tests, and continuously monitoring impurity levels at different stages of the manufacturing process.
What are the different inorganic impurities in Sorafenib?
Inorganic impurities in Sorafenib can be due to the raw materials used during manufacturing, which may include substances such as heavy metals or other contaminants—underscoring the importance of vigilant monitoring and stringent control measures to uphold Sorafenib's quality and safety standards as a pharmaceutical product.
Why is the presence of impurities a concern in Sorafenib?
Depending on the type and level of impurities, they can impact the drug's pharmacological activity and stability and pose potential risks to patient health.
What are the temperature conditions required to store Sorafenib Impurities?
Sorafenib Impurities are stored at a controlled room temperature between 2-8 °C or as indicated on the Certificate of Analysis (CoA).
Note: Products protected by valid patents by a manufacturer are not offered for sale in countries having patent protection. The sale of such products constitutes a patent infringement, and its liability is at the buyer's risk.